Atorvastatin action involves diminished recovery of hepatic HBG-CoA reductase activity

Journal of Lipid Research

Volumn 39, Issue 1, 1998, Pages 75-84

  Ness, Gene C ^a   Chambers, Christopher M ^a   Lopez, Dayami ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Atorvastatin; HMG CoA reducrase inhibitors immunoblotting Northern blotting; Iovastatin; LDL receptor

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL SYNTHESIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; LIPID LIVER LEVEL; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RECEPTOR DENSITY;

ANIMALS; CHOLESTEROL; GENE EXPRESSION; HALF-LIFE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IRRIGATION; LIVER; MALE; MICROSOMES, LIVER; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; RNA, MESSENGER; UP-REGULATION;

EID: 0031930805     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Endo, A. 1992. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33: 1569-1582.
2. Bradford, R. H., C. L. Shear, A. N. Chremos, C. Dujovne, M. Downtown, F. A. Franklin, A. L. Gould, M. Hesney, J. Higgins, P. D. Hurley, A. Langendorfer, D. T. Nash, J. L. Pool, and H. Schnaper. 1991. Expanded clinical evaluation of lovastatin (EXCEL) study results. Arch. Intern. Med. 151: 43-49.
3. Waters, D., L. Higginson, P. Gladstone, B. Kimball, M. L. May, S. J. Boccuzzi, J. Lesperance, and the CCAIT Study Group. 1994. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention Trial. Circulation. 89: 959-968.
4. Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389.
5. Ness, G. C., S. Eales, D. Lopez, and Z. Zhao. 1994. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and non-sterols in rat liver. Arch. Biochem. Biophys. 308: 420-425.
6. Ness, G. C., Z. Zhao, and D. Lopez. 1996. Inhibitors of cholesterol biosynthesis increase hepatic low density lipoprotein receptor protein degradation. Arch. Biochem. Biophys. 325: 242-248.
7. Goldberg, I. J., S. Holleran, R. Ramakrishnan, M. Adams, R. H. Palmer, R. B. Dell and D. W. Goodman. 1990. Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism. J. Clin. Invest. 86: 801-808.
8. Goldstein, J. L., H. H. Hobbs, and M. S. Brown. 1995. Familial hypercholesterolemia. In The Metabolic and Molecular Basis of Inherited Disease, Vol. II, seventh ed. McGraw-Hill, Inc., New York. 1981-2030.
9. Nawrocki, J. W., S. R. Weiss, M. H. Davidson, D. L. Sprecher, S. L. Schwartz, P. J. Lupien, P. H. Jones, H. E. Haber, and D. M. Black. 1995. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler. Thromb. Vasc. Biol. 15: 678-682.
10. Auerback, B. J., B. R. Krause, C. L. Bisgaier, and R. S. Newton. 1995. Comparative effects of HMG-CoA reductase inhibitors on apoB production in the casein-fed rabbit: atorvastatin versus lovastatin. Atherosclerosis. 115: 173-180.
11. Conde, K., M. Vergara-Jimenez, B. R. Krause, R. S. Newton, and M. L. Fernandez. 1996. Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig. J. Lipid Res. 37: 2372-2382.
12. Ness, G. C., and Z. Zhao. 1994. Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. Arch. Biochem. Biophys. 315: 199-202.
13. Singer, I. I., D. W. Kawka, D. M. Kazazes, A. W. Alberts, J. S. Chen, J. W. Huff, and G. C. Ness. 1984. Hydroxymethylglutaryl coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat liver. Proc. Natl. Acad. Sci. USA. 81: 5556-5560.
14. Ness, G. C., Z. Zhao, and R. K. Keller. 1994. Effects of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor and cholesterol 7α-hydroxylase. Arch. Biochem. Biophys. 311: 277-285.
15. Walker, R. F., G. C. Ness, Z. Zhao, and B. B. Bercu. 1994. Effects of stimulated growth hormone secretion on age-related changes in plasma cholesterol and hepatic low density lipoprotein receptor mRNA concentrations. Mech. Ageing Dev. 75: 215-226.
16. Rudling, M., and G. Angelin. 1993. Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic LDL receptor expression. Proc. Natl. Acad. Sci. USA. 90: 8851-8855.
17. Ness, G. C., and D. Lopez. 1995. Transcriptional regulation of rat hepatic low density lipoprotein receptor and cholesterol 7α-hydroxylase by thyroid hormone. Arch. Biochem. Biophys. 323: 404-408.
18. Krause, B. R., and R. S. Newton. 1995. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis. 117: 237-244.
19. Keller, R. K., Z. Zhao, C. Chambers and G. C. Ness. 1996. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. Arch. Biochem. Biophys. 328: 324-330.
20. Simonet, W. S., and G. C. Ness. 1988. Transcriptional and postranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase by thyroid hormone. J. Biol. Chem. 263: 12448-12453.
21. Ness, G. C., D. Lopez, O. Borrego, and E. Gilbert-Barness. 1997. Increased expression of low-density lipoprotein receptors in a Smith-Lemli-Opitz infant with elevated bilirubin levels. Am. J. Med. Genet. 68: 294-299.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162: 156-159.
23. Ness, G. C., C. E. Sample, M. Smith, L. C. Pendleton, and D. C. Eichler. 1986. Characteristics of rat liver microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochem. J. 233: 167-172.
24. Ness, G. C., and C. M. Chambers. 1996. The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein. Arch. Biochem. Biophys. 327: 41-44.
25. Ness, G. C., L. C. Pendleton, and A. S. Pendleton. 1987. Loss of NADPH during assays of HMG-CoA reductase: implications and approaches to minimize errors. Lipids. 22: 409-412.
26. Lee, Y. P., and H. A. Lardy. 1965. Influence of thyroid hormones on L-α-glycerophosphate dehydrogenase and other dehydrogenases in various organs of the rat. J. Biol. Chem. 240: 1427-1436.
27. Burnett, J. R., D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff. 1995. Atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. XII International Symposium on Drugs Affecting Lipid Metabolism. Abstract: 115.
28. Shaw, M. K., R. S. Newton, D. R. Sliskovic, B. D. Roth, E. Ferguson, and B. R. Krause. 1990. HepG2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductase. Biochem. Biophys. Res. Commun. 170: 726-734.
29. Simonet, W. S., and G. C. Ness. 1989. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA in rat liver. Glucocorticoids block the stabilization caused by thyroid hormone. J. Biol. Chem. 264: 569-573.
30. Naoumova, R. P., A. D. Marais, J. Mountney, J. C. Firth, I N. B. Rendell, G. W. Taylor, and G. R. Thompson. 1996. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolemia. Atherosclerosis. 119: 203-213.
31. Chambers, C. M., and G. C. Ness. 1997. Translational regulation of hepatic HMG-CoA reductase by dietary cholesterol. Biochem. Biophys. Res. Commun. 232: 278-281.
32. Spady, D. K., E. F. Stange, L. E. Bilhartz, and J. M. Dietschy. 1986. Bile acids regulate hepatic low density lipoprotein receptor activity in the hamster by altering cholesterol flux across the liver. Prof. Natl. Acad. Sci. USA. 83: 1916-1920.